CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 189 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $465,000 | +56.0% | 29,631 | +4.7% | 0.00% | +100.0% |
| Q3 2015 | $298,000 | -87.1% | 28,309 | -69.2% | 0.00% | -83.3% |
| Q2 2015 | $2,318,000 | -18.9% | 91,912 | -10.3% | 0.01% | -29.4% |
| Q1 2015 | $2,857,000 | -75.0% | 102,494 | -83.6% | 0.02% | -76.7% |
| Q4 2014 | $11,439,000 | +42.1% | 626,812 | +0.9% | 0.07% | +128.1% |
| Q3 2014 | $8,051,000 | +85.1% | 621,189 | +133.1% | 0.03% | +45.5% |
| Q2 2014 | $4,350,000 | – | 266,535 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |